- January 15, 2025
Yale-Led Study Will Compare Effectiveness of IV Ketamine and Esketamine Nasal Spray
- December 09, 2024Source: The New York Times
Common Questions About Antidepressants, Answered
- October 24, 2024Source: Yale Medicine
Electroconvulsive Therapy (ECT) Has Changed: What You Should Know
- October 03, 2024Source: Yale Daily News
Yale mental health experts weigh in on increasing national suicide rates
- October 02, 2024
Bipolar Disorder Patients Respond to Ketamine, Esketamine Treatment
- August 20, 2024Source: The Wall Street Journal
People Are Injecting Ketamine at Home
Yale Depression Research Program
Operated jointly by the Yale University School of Medicine Department of Psychiatry and Connecticut Mental Health Center, the Yale Depression Research Program has, for over 30 years, been committed to advancing the treatment of depression. By engaging in studies that seek to elucidate the underlying neurobiology of depression, we are striving to improve our ability to diagnose and treat mood disorders.
Executive Director, Gerard Sanacora, MD, PhD
Depression remains one of the most common and debilitating medical problems throughout the world. At the Yale Depression Research Program, we are committed to advancing our ability to understand, diagnose, and treat depression through innovative research.